The emerging legal cannabis industry in Germany is one of the most exciting markets globally by many measures. Legal medical cannabis sales through pharmacies launched in the European nation in 2017, and lawmakers approved a historic national adult-use cannabis legalization measure in 2024. A considerable amount of market data is now flowing out of Germany, providing valuable insights for investors, entrepreneurs and policymakers.
As Germany’s medical cannabis sector has progressed and matured over the years, it has become clearer just how many patients the sector serves. Unlike state-level medical cannabis programs in the United States, in which there is typically a central registry that makes it easier to pinpoint the number of registered patients at any given time, Germany’s patient count is less straightforward to calculate. Some medical cannabis patients receive reimbursements through the public healthcare system, while others are “self-payers” and acquire their medicine through private means.
Evaluating Germany’s Medical Cannabis Patient Count
According to leading international cannabis economist Beau Whitney, founder of Whitney Economics, there are an estimated 200k-300k medical cannabis patients in Germany who are not self-payers, and an estimated 500k-600k self-paying medical cannabis patients in the country. The rise in the use of telemedicine in Germany in recent years has directly contributed to a steady increase in medical cannabis patients making their purchases through legal sources.
Another major contributing factor to increased legal safe medical cannabis access in Germany is the number of medical cannabis pharmacies operating in the European nation. As cited in a German Cannabis Business Association (BvCW) newsletter, roughly 2,500 of Germany’s 17,000 registered pharmacies now offer medical cannabis.
Medical Cannabis Imports
One of the most insightful sources of data that puts into context how much Germany’s medical cannabis industry has increased in size in recent years pertains to medical cannabis imports. Germany’s Federal Institute for Drugs and Medical Devices (BfArM) publishes quarterly data for imports, and in just the third quarter of 2025 alone, Germany imported nearly 57 tons of medical cannabis products.
To put that figure into perspective, consider that in the third quarter of 2024, about 20.654 tons of medical cannabis products were imported, which was a record at that time. In the first nine months of 2025, Germany imported over 142 tons of medical cannabis products. That is a mind-boggling amount, and a testament to the growth of Germany’s legal medical cannabis industry.
Researchers at the IPE Institute for Policy Evaluation conducted a market analysis, determining that Germany’s self-payer medical cannabis market may be worth as much as 2.9 billion euros annually. That is a massive cost saving for Germany’s public healthcare system.
Widespread Benefits
The rise
